The Pillar of
Regenerative Research
Regenerative Medicine Research Institute, is the research arm of RM Global. Our research focuses on developing novel therapies to address unmet needs in regenerative medicine with a key focal point in cancer therapies. One of its areas of focus is reducing the death rate associated with Ocular Graft versus Host disease (oGVHD), a devastating medical condition affecting thousands of people with a mortality rate of over 50%. Regenerative Ocular Immunobiologics (ROI), also a company within the family of RM Global will be the entity doing the clinical trials to offer hope in treating oGVHD with its innovative technology that effectively treats dry eye, a common symptom of oGVHD. RM Global's success is attributed to its Advisory Board and Founder Dr. C. Randall Harrell's 50 years of experience in stem cell research, contributing breakthroughs to the field.
Innovation & Intellectual Property Tracker
Patents
Trademarks
69
Peer-Reviewed Scientific White Papers
12
Peer-Reviewed
Book Chapters
48
134
THE
TEAM
This company is made up of a group of highly intelligent, creative, and talented individuals who are passionate about challenging the status quo and pushing the boundaries of what is possible. They bring diverse expertise and backgrounds to the table, united by a shared commitment to excellence and a desire to make a positive impact on the world through their work in regenerative medicine.